| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/31/2004 | EP1402256A2 P-cadherin as a target for anti-cancer therapy |
| 03/31/2004 | EP1402070A2 Methods for the diagnosis of cancer based on the obcam and ntm genes |
| 03/31/2004 | EP1402067A2 HS2STs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE |
| 03/31/2004 | EP1402066A2 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
| 03/31/2004 | EP1402058A2 Dgks as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1402054A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 03/31/2004 | EP1402053A2 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 03/31/2004 | EP1402043A1 Methods of administering vectors to synaptically connected neurons |
| 03/31/2004 | EP1402034A2 Identification of ses-1 and the uses of the same |
| 03/31/2004 | EP1402031A2 Atopy |
| 03/31/2004 | EP1402023A2 Method for generating replication defective viral vectors that are helper free |
| 03/31/2004 | EP1402021A1 A gene and uses therefor |
| 03/31/2004 | EP1402019A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 03/31/2004 | EP1402018A1 Unigene unidirectional antisense library |
| 03/31/2004 | EP1402017A1 Random gene unidirectional antisense library |
| 03/31/2004 | EP1402007A1 Bcl-2 dnazymes |
| 03/31/2004 | EP1401999A2 B7 related protein-2 molecules and uses thereof |
| 03/31/2004 | EP1401918A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 03/31/2004 | EP1401871A1 Immunological binding molecules inhibiting the syncytial fusion of trophoblast cells |
| 03/31/2004 | EP1401867A2 Mycobacterial antigens expressed under low oxygen tension |
| 03/31/2004 | EP1401861A2 Cads as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1401859A2 Chimeric flavivirus vectors |
| 03/31/2004 | EP1401858A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/31/2004 | EP1401855A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 03/31/2004 | EP1401853A1 Modulators of pharmacological agents |
| 03/31/2004 | EP1401486A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 03/31/2004 | EP1401482A1 Yin yang-1 |
| 03/31/2004 | EP1401480A2 Use of endostatin in the treatment of ocular neovascularization |
| 03/31/2004 | EP1401475A2 Prmts as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1401472A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 03/31/2004 | EP1401468A2 Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases |
| 03/31/2004 | EP1401443A1 Novel anti-infectives |
| 03/31/2004 | EP1401376A2 Colloidal metal compositions and methods |
| 03/31/2004 | EP1401375A2 Methods for inhibiting macrophage colony stimulating factor and c-fms-dependent cell signaling |
| 03/31/2004 | EP1401281A2 Toll/interleukin-1 receptor adaptor protein (tirap) |
| 03/31/2004 | EP1401276A2 Implantation of biological pacemaker that is molecularly determined |
| 03/31/2004 | EP1401268A1 Treatment or replacement therapy using transgenic stem cells delivered to the gut |
| 03/31/2004 | EP1250156A4 Method for nucleic acid transfection of cells |
| 03/31/2004 | EP1230341A4 Geranyl diphosphate synthase large subunit, and methods of use |
| 03/31/2004 | EP1230338A4 Continuous-flow method for preparing microparticles |
| 03/31/2004 | EP1181318B1 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 03/31/2004 | EP1049484B1 Use of il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer |
| 03/31/2004 | EP0866860B1 Novel tyrosine kinase receptors and ligands |
| 03/31/2004 | EP0784677B1 Inhibitor of stem cell proliferation and uses thereof |
| 03/31/2004 | EP0746625B1 Targetable vector particles |
| 03/31/2004 | EP0735818B1 MACROPHAGE INFLAMMATORY PROTEINS MIP-3, MIP-4 AND MIP-1gamma |
| 03/31/2004 | EP0681477B1 Genetic modification of neural stem cells |
| 03/31/2004 | EP0656948B1 Bordetella bronchiseptica vaccine |
| 03/31/2004 | CN1486327A 载脂蛋白类似物 Apolipoprotein analogues |
| 03/31/2004 | CN1144019C Ceramic packing with channels for thermal and catalytic bed |
| 03/30/2004 | US6713621 Chimeric compositions having multi-modalities are also provided which can affect a plurality of gene functions by interfering with splicing or translation as well as transcription |
| 03/30/2004 | US6713607 Effector proteins of Rapamycin |
| 03/30/2004 | US6713457 Strategy for suppressing the expression of an endogeneous gene by using compounds that are able to bind to the non-coding regions of the gene to be suppressed |
| 03/30/2004 | US6713456 Nucleozymes |
| 03/30/2004 | US6713293 Encapsulated cells containing an amplified expression vector as a drug delivery device |
| 03/30/2004 | US6713291 Method of immunotherapy; obtain electrodes, obtain waveform generator, generate electrically conductive pathways between electrodes and generator, incubate with transfer particles, transfer particles into cells with electrical pulse |
| 03/30/2004 | US6713247 Human CNS cell lines and methods of use therefor |
| 03/30/2004 | US6713068 Live recombined vaccines injected with adjuvant |
| 03/30/2004 | US6713067 Which: (i) lacks a functional vhs gene, or a functional equivalent thereof; and (ii) comprises a functional ul43 gene, or a functional equivalent thereof such that dendritic cells are infected with said virus. |
| 03/30/2004 | US6713065 Methods of using hedgehog proteins to modulate hematopoiesis and vascular growth |
| 03/30/2004 | US6713061 Death domain containing receptors |
| 03/30/2004 | US6713055 Glycosyltransferase vectors for treating cancer |
| 03/30/2004 | CA2411508A1 Methods for polysaccharide adhesin synthesis modulation |
| 03/30/2004 | CA2277165C Purification and/or concentration of dna by cross-flow filtration, separation of endotoxins from a nucleic acid preparation |
| 03/27/2004 | CA2405652A1 Augmentation of k+ channel expression using adenoviral vectors |
| 03/25/2004 | WO2004025267A2 Method for testing drug susceptibility of hiv |
| 03/25/2004 | WO2004025263A2 Protein and peptide expression for passive immunity |
| 03/25/2004 | WO2004024952A1 Method of diagnosing ovarian endometriosis |
| 03/25/2004 | WO2004024919A1 Non-sequence complementary antiviral oligonucleotides |
| 03/25/2004 | WO2004024909A2 Recombinant colstridium neurotoxin fragments |
| 03/25/2004 | WO2004024906A1 Nucleoside triphosphate diphosphohydrolase (ntpdase 8) and uses thereof |
| 03/25/2004 | WO2004024904A2 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 03/25/2004 | WO2004024872A2 Method for expression of small antiviral rna molecules within a cell |
| 03/25/2004 | WO2004024190A2 Recombinant lentivirale vector pseudotyped with the hemagglutinin protein for gene transfer into the retina |
| 03/25/2004 | WO2004024174A1 Method and composition for regulating the activity of regulatory t cells |
| 03/25/2004 | WO2004024087A2 Methods of diagnosing and treating hyperproliferative disorders |
| 03/25/2004 | WO2004024082A2 Highly specific modulators of gtpases for target validation |
| 03/25/2004 | WO2004023869A1 Use of plag or plag-inhibitors to diagnose and/or treat disease |
| 03/25/2004 | WO2004007718A3 Rna-interference by single-stranded rna molecules |
| 03/25/2004 | WO2003093485A3 Optimization of transgene expression in mammalian cells |
| 03/25/2004 | WO2003087154A3 Sequences involved in the phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses, and the use of the same as medicaments |
| 03/25/2004 | WO2003076591A3 Compositions and methods for generating an immune response |
| 03/25/2004 | WO2003068944A3 METHODS AND COMPOSITION FOR MODULATING TYPE I MUSCLE FORMATION USING PGC-1α- |
| 03/25/2004 | WO2003066104A3 Pharmaceutical composition which improves in vivo gene transfer |
| 03/25/2004 | WO2003051923A3 Novel g-protein coupled receptors and dna sequences thereof |
| 03/25/2004 | WO2003040296A3 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 03/25/2004 | WO2003039475A3 Methods of identifying and using modulators of fractalkine receptor |
| 03/25/2004 | WO2003015812A3 Beta-amyloid-analogue-t-cell epitop vaccine |
| 03/25/2004 | WO2003015612A3 Materials and methods to promote repair of nerve tissue |
| 03/25/2004 | WO2003011008A3 Therapeutic delivery compositions and methods of use thereof |
| 03/25/2004 | WO2002089832A3 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
| 03/25/2004 | WO2002083859A8 Surface proteins of streptococcus pyogenes |
| 03/25/2004 | WO2002076394A3 Enzyme-based anti-cancer compositions and methods |
| 03/25/2004 | WO2001092470A3 Dna expression vectors and methods of use |
| 03/25/2004 | WO2001049118A8 Compositions comprising genome segments and methods of using the same |
| 03/25/2004 | US20040059087 Peptide nucleic acids |
| 03/25/2004 | US20040058882 Microseeding device for gene delivery by microneedle injection |
| 03/25/2004 | US20040058870 Reduce blood glucose concentration; antidiabetic agent; respiratory system disorders |
| 03/25/2004 | US20040058869 Methods and reagents for modulating cholesterol levels |
| 03/25/2004 | US20040058849 Fibroblast growth factor receptors and methods for their use |